Oncology Institute Inc. CW-22STLNWPreferred / convertible

13F holders, Q1 2024 (March 31)
15holders
1famous investor
$0.20avg. 13F price*

At the end of Q1 2024, 15 institutions reported holding Oncology Institute Inc. CW-22 (STLNW) in their 13F filings. The largest holders were LMR Partners LLP ($325K), Deerfield Management Company, L.P. ($250K) and Walleye Capital LLC ($79K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).

Company
Oncology Institute Inc. CW-22
Filed as
THE ONCOLOGY INSTITUTE INC (Q1 2024)
CUSIP
68236X118
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q1 2024: 15Q1 2024Q2 2024: 18Q2 2024Q3 2024: 15Q3 2024Q4 2024: 14Q4 2024Q1 2025: 11Q1 2025Q2 2025: 11Q2 2025Q3 2025: 12Q3 2025Q4 2025: 11Q4 2025Q1 2026: 11Q1 2026Q2 2026: 12Q2 2026

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions0$0
Exits1$63K

Ownership 15 holders

LMR Partners LLP — No change 1,624,856 $325K
Deerfield Management Company, L.P. — No change 1,250,000 $250K
Walleye Capital LLC — No change 393,545 $79K
Davidson Kempner Capital Management LP — No change 318,710 $64K
FreeGulliver LLC — Add +527.8% 116,150 $23K
Man Group plc — No change 88,824 $20K
Healthcare of Ontario Pension Plan Trust Fund — No change 87,500 $19K
Cowen and Company, LLC — Reduce -28.7% 86,726 $17K
Wolverine Asset Management LLC — Reduce -17.4% 54,570 $11K
Two Sigma Investments, LP — No change 30,000 $6K
Alpine Global Management, LLC — No change 25,024 $5K
TENOR CAPITAL MANAGEMENT Co., L.P. — No change 25,000 $5K
Citadel Advisors — Reduce -39.8% 13,374 $3K
Clear Street LLC — No change 1,593 $319
Bank of America Corp. — No change 200 $40

"% of holder's portfolio" is STLNW's weight in each manager's 13F, not the share of Oncology Institute Inc. CW-22 the manager owns.